Rehabilitation program for lung cancer patients
Cross-sectorial Rehabilitation of Patients with Lung Cancer
This study is testing a new way to help lung cancer patients get involved in rehabilitation programs earlier to see if it improves their physical abilities and quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 130 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Copenhagen University Hospital at Herlev Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Herlev, Denmark) |
| Trial ID | NCT06705465 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to improve the participation of lung cancer patients in rehabilitation programs through an 'early contact conference' approach. It involves collaboration between the Department of Oncology and municipal rehabilitation services, utilizing video conferencing to facilitate communication. The study will assess whether this intervention enhances patients' physical abilities and quality of life. Thirteen municipalities in Region Hovedstaden will participate in this cluster randomized controlled trial, focusing on patients diagnosed with non-small cell lung cancer (NSCLC) undergoing systemic treatment.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with non-small cell lung cancer who are undergoing their first line of systemic treatment.
Not a fit: Patients who cannot communicate in Danish or are cognitively unfit to provide consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life and physical capabilities of lung cancer patients through better access to rehabilitation services.
How similar studies have performed: Other studies have shown promising results with similar rehabilitation approaches, indicating potential for success in this novel intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients diagnosed with NSCLC * 1\. line systemic treatment Exclusion Criteria: * cannot speak, understand, and/or read Danish * cognitive/psychologically unfit to give consent
Where this trial is running
Herlev, Denmark
- Herlev and Gentofte Hospital — Herlev, Denmark, Denmark (Recruiting)
Study contacts
- Study coordinator: Camilla S Balle, PhD student
- Email: camilla.sick.balle@regionh.dk
- Phone: +45 51332047
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.